title: Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results.
authors.affiliation: Roche Laboratories Inc., Nutley, New Jersey, USA.
authors.forename: E E
authors.initials: EE
authors.lastname: Hodge
authors.forename: D J
authors.initials: DJ
authors.lastname: Reich
authors.forename: P A
authors.initials: PA
authors.lastname: Clavien
authors.forename: L
authors.initials: L
authors.lastname: Kim-Schluger
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications*; D007677:Kidney Function Tests; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000276:immunology*; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D003404:Creatinine; D009173:Mycophenolic Acid; D016559:Tacrolimus